7 Nov 2024
PhD Candidate Nate Shannon's first author paper out as a pre-print. Very proud of Nate! Some very interesting DEGs dependent on Miro1 expression and an interesting and evolving cell cycle/ERK1/2 story! @UVMcancercenter @RedoxVT #mitochondria
biorxiv.org/content/10.1101/…
1
1
4
119
13 Jun 2024
NEW @NatureCellBio study finds glutathione S transferase theta drives pancreatic cancer metastasis by targeting fibronectin which places redox reactions front and center in tumor metastatic behavior.
Congrats @RedoxVT on supporting these findings!
go.nature.com/4aVXWAE
2
2
490
13 Jun 2024
NEW @NatureCellBio study finds glutathione S transferase theta drives pancreatic cancer metastasis by targeting fibronectin which places redox reactions front and center in tumor metastatic behavior.
Congrats @RedoxVT on supporting these findings!
go.nature.com/4aVXWAE
4
6
907
29 May 2024
Excited to see Dean present exciting data around the Phase 1 trial of RSO-021 at #ASCO24. A redox-dependent cancer therapy currently being tested in Phase 2! @RedoxVT @UVMcancercenter @dean_fennell @RSOncologyLLC x.com/RSOncologyLLC/status/1…
1
2
472
10 Apr 2024
Always an excellent meeting with great science and clinical progress being showcased! @RedoxVT @UVMcancercenter @RSOncologyLLC
9 Apr 2024
Sharing our 🔬scientific findings and preclinical data🫁. If you are at #AACR24 #SanDiego stop by today to see our presentation ~ @9am_today Titled: First-in-class peroxiredoxin 3 (PRX3) inhibitor RSO-021 triggers mesenchymal-to-epithelial transition in #meso. #taketwo
1
7
194
3 Apr 2024
3 Apr 2024
Presenting two posters with new discoveries 🔬and potential biomarkers associated with RSO-021 anticancer activity @AACR San Diego, April 7th and April 9th. George Naumov will be there along with Brian Cunniff @CunniffLab, will you? #biotech #CancerResearch
2
84
26 Mar 2024
Really look forward to meet up with my great colleagues and participate in this inaugural conference. @RedoxVT proud to be part of this effort!
26 Mar 2024
Now we are ready to welcome the participants of The 1st International G-ReXS Conference in Sendai. We have excellent speakers lineup.
#supersulfide #redox #sendai #japan
sites.google.com/view/g-rexs…
9
199
1 Feb 2024
Exciting news! @RedoxVT
1 Feb 2024
BIG NEWS! Groundbreaking anticancer drug moves to phase 2 expansion study @dean_fennell @CR_UK @STS_CTsurgery @asthmalunguk @LeicesterCTU
businesswire.com/news/home/2…
4
147
12 Sep 2023
It's official - Phase 1 complete! Beyond grateful to the patients, caregivers and clinical teams for their participation and support. @RedoxVT @UVMcancercenter
12 Sep 2023
Excited to share our big news!! We completed phase 1 of #MITOPE clinical trial!! 😀👏👏
finance.yahoo.com/news/rs-on…
1
4
162
4 Aug 2023
Very encouraging to see patients responding to a new therapy for mesothelioma and to see our findings translated to the clinic! finance.yahoo.com/news/rs-on…
@RSOncologyLLC @RedoxVT @UVMcancercenter @dean_fennell
1
119
20 Apr 2023
A nice write up by @UVMLarnerMed about our recent studies! @RedoxVT
van der Vliet's Study Finds Potential New Treatment Target for Obesity-Associated Asthma med.uvm.edu/home/2023/04/19/…
2
9
615
28 Mar 2023
.@AJPLung #APSselect study finds diet-induced #obesity makes allergy-related airway inflammation worse. Read press release and watch interview with @VlietAlbert: ow.ly/8QnE50NtBxo CC: @RedoxVT @VTLungCenter
4
2,537
13 Mar 2023
Congratulations to @AJPLung March #APSselect winners Habibovic, @VlietAlbert et al. for “Diet-induced obesity worsens allergen-induced type 2/type 17 inflammation in airways by enhancing DUOX1 activation”.
ow.ly/ploH50NaUKT
@RedoxVT @VTLungCenter @UVMLarnerMed
4
7
747
6 Mar 2023
07/03 🔥 😃 Don't miss our @SFRR_Europe ECR seminar "NOX4: From discovery to therapeutics" with Louise Hecker. Learn about the latest NOX4 research and its potential for innovative therapies. Please RT @SFRBM @WakeRedox @RedoxVT
6
16
1,419
16 Feb 2023
Excited to present our work on targeting mitochondrial redox status in malignant mesothelioma! @RedoxVT @RSOncologyLLC
16 Feb 2023
The 16th International Conference of the The International Mesothelioma Interest Group @imig2023 will take place in Lille, France from 26 - 28 June 2023.
It's set to be an excellent, informative event. You can find out moe and register on the website at imig2023.org
2
12
656
Check out this recent publication from RedoxVT faculty @VlietAlbert and his collaborators in @APSPhysiology addressing altered redox mechanisms in obesity associated allergic asthma
journals.physiology.org/doi/…
4
266
11 Jan 2023
Check out our latest paper with colleagues from @RedoxVT and @VTLungCenter addressing altered redox mechanisms in obesity-associated allergic asthma.journals.physiology.org/doi/…
2
7
495
22 Dec 2022
Read about our ongoing interactions between members of our UVM redox program @RedoxVT and colleagues at Tohoku University in Japan. med.uvm.edu/home/2022/12/22/…
3
205
4 Jun 2022
Yes, it was great to meet her! I believe she had a great meeting. She looks pretty happy in the picture. I bet bet you’re happy that she was able to attend and make valuable connections!
1
4 Jun 2022
The 2022 NOX GRC @GordonConf at Mount Snow is now officially in the books! I was pleased to see everyone enjoy it and for the highly positive and collegial spirit throughout the meeting. Hope we can do this again soon!! @YvonneJanssenh1 @RedoxVT
1
8